Abstract:Background: Obstructive sleep apnoea (OSA) is a common sleep disorder featuring intermittent hypoxia and sleep fragmentation, which may contribute to the occurrence of cardiovascular diseases. However, its aetiology remains unclear. Emerging observational studies have revealed an association between the gut microbiome and OSA, but few have proven a causal link between them.Methods: Based on the results of a genome-wide association study (GWAS) of the gut microbiome and OSA, we performed two-sample mendelian randomisation analysis to examine the causal relationship between the gut microbiome and OSA. Single-nucleotide polymorphisms related to the composition of the human gut microbiome from a multi-ethnic large-scale GWAS that recruited 24 population-based cohorts including 18,340 individuals were selected as instrumental variables (IVs). Two sets of IVs selected based on genome-wide statistical significance (p < 5 × 10-8) and locus-wide significance (p < 1 × 10-5) were used to estimate the causal links between the gut microbiome and six quantitative traits of OSA. GWAS summary apnoea–hypopnoea index (AHI) data were obtained from a multi-ethnic meta-analysis including 19,733 individuals of mixed ethnicity. GWAS data related to oxygen saturation in OSA consisted of a discovery sample (8326 individuals) and a replication group (14410 individuals).Findings: We found that the phylum Actinobacteria (β = −0.463, SE = 0.230, p = 0.0438) was a protective factor for OSA, while the genus Eubacterium coprostanoligenes group (β = 0.916, SE = 0.258, p = 0.0004) was a risk factor for a higher apnoea–hypopnoea index during NREM sleep. The genera Tyzzerella 3 (β = −0.245, SE = 0.092, p = 0.0074) and Streptococcus (β = −0.581, SE = 0.171, p = 0.0007) were associated with a lower average oxygen saturation. Additional gut microbiome taxa were found to have causal links with OSA when estimated by locus-wide significate IVs, such as the phylum Firmicutes, class Clostridia, and genus Lactococcus.Interpretation: This study indicates that gut microbiome taxa have beneficial or detrimental causal effects on OSA risk, which may provide incentive for developing adjuvant therapies for OSA that target the gut microbiome.Clinical Trial Registration Details: Funding Information: This study was supported by National Natural Science Foundation of China (81970870, 81770987) and the Three-Year Action Plan of Promoting Clinical Skills and Clinical Innovation in Shanghai Shenkang Medical Center (No. SHDC2020CR2044B; SHDC2020CR3056B).Declaration of Interests: All the authors declare that they have no conflict of interest with the contend of this article.Ethics Approval Statement: MISSING

Pain, obesity, adenosine salvage disruption, and smoking behavior mediate the effect of gut microbiota on sleep disorders: results from network Mendelian randomization and 16S rDNA sequencing

Association between sleep-related phenotypes and gut microbiota: a two-sample bidirectional Mendelian randomization study

Causal Effects of Gut Microbiota on Sleep-Related Phenotypes: A Two-Sample Mendelian Randomization Study

Causality Investigation between Gut Microbiota, Derived Metabolites, and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study

A Mendelian randomization investigation of the causal association between the gut microbiota and sleep disorders

Gut Microbiome Composition and Its Association with Sleep in Major Psychiatric Disorders

Causal relationships between gut microbiome and obstructive sleep apnea: a bi-directional Mendelian randomization

Associations between gut microbiota and sleep: a two-sample, bidirectional Mendelian randomization study

Causality Investigation between Gut Microbiome and Sleep-Related Traits: A Bidirectional Two-Sample Mendelian Randomization Study

Metabolic Characteristics of Gut Microbiota and Insomnia: Evidence from a Mendelian Randomization Analysis

The relationship between gut microbiota and insomnia: a bi-directional two-sample Mendelian randomization research

Causal Effect of Gut Microbiome on Quantitative Traits of Obstructive Sleep Apnea: A Two Sample Mendelian Randomization Study

Assessing the Causal Association Between Sleep Apnea and the Human Gut Microbiome Composition: A Two-Sample Mendelian Randomization Study

Causal relationship between the gut microbiota and insomnia: a two-sample Mendelian randomization study

Genetic evidence for the causal impact of insomnia on gastrointestinal diseases and the mediating effects of adiposity traits

Association between mobile phone addiction, sleep disorder and the gut microbiota: a short-term prospective observational study

Alterations in Gut Microbiota Are Correlated With Serum Metabolites in Patients With Insomnia Disorder

Evaluating the Effects of Diet-Gut Microbiota Interactions on Sleep Traits Using the UK Biobank Cohort

The Component and Functional Pathways of Gut Microbiota Are Altered in Populations with Poor Sleep Quality – A Preliminary Report

Exploring the bidirectional causal association between Sleep Apnea Syndrome and Depression: A Mendelian randomization study involving gut microbiota, serum metabolites, and inflammatory factors

Investigating the causal links between obstructive sleep apnea and gastrointestinal diseases mediated by metabolic syndrome through mendelian randomization